These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 33052231)

  • 1. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
    Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
    Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
    [No Abstract]   [Full Text] [Related]  

  • 2. SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
    Wang C; Li Y; Wang L; Han Y; Gao X; Li T; Liu M; Dai L; Du R
    Br J Cancer; 2024 May; 130(11):1770-1782. PubMed ID: 38600327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived exosomal hyaluronidase 1 induced M2 macrophage polarization and promoted esophageal cancer progression.
    Yuan J; Hou B; Guo K; Zhu J; Xiao H
    Exp Cell Res; 2024 Jun; 439(1):113963. PubMed ID: 38382806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma.
    Yuan X; Li Y; Zhang AZ; Jiang CH; Li FP; Xie YF; Li JF; Liang WH; Zhang HJ; Liu CX; Pang LJ; Shen XH; Li F; Hu JM
    Aging (Albany NY); 2020 Dec; 13(2):2049-2072. PubMed ID: 33323552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase.
    Mai S; Liu L; Jiang J; Ren P; Diao D; Wang H; Cai K
    Cell Prolif; 2021 Feb; 54(2):e12960. PubMed ID: 33305406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
    Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
    Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated Fibroblast-promoted LncRNA
    Zhang H; Hua Y; Jiang Z; Yue J; Shi M; Zhen X; Zhang X; Yang L; Zhou R; Wu S
    Clin Cancer Res; 2019 Mar; 25(6):1989-2000. PubMed ID: 30463848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Derived Exosomal miR-143-3p Induces Macrophage M2 Polarization to Cause Radiation Resistance in Locally Advanced Esophageal Squamous Cell Carcinoma.
    Gao LR; Zhang J; Huang N; Deng W; Ni W; Xiao Z; Liu M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeobox A7 promotes esophageal squamous cell carcinoma progression through C-C motif chemokine ligand 2-mediated tumor-associated macrophage recruitment.
    Feng A; He L; Jiang J; Chu Y; Zhang Z; Fang K; Wang Z; Li Z; Sun M; Zhao Z; Shi J; Zhang L; Chen T; Xu M
    Cancer Sci; 2023 Aug; 114(8):3270-3286. PubMed ID: 37248653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization.
    Guo H; Shu J; Hu G; Liu B; Li J; Sun J; Wang X; Liu H; Xiong S; Tang Y; Yin Y; Wang X
    PLoS One; 2024; 19(5):e0302780. PubMed ID: 38713738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma.
    Gopalan V; Islam F; Pillai S; Tang JC; Tong DK; Law S; Chan KW; Lam AK
    Exp Cell Res; 2016 Nov; 348(2):146-154. PubMed ID: 27658568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Liu M; Li F; Liu B; Jian Y; Zhang D; Zhou H; Wang Y; Xu Z
    BMC Med Genomics; 2021 Mar; 14(1):75. PubMed ID: 33691689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
    Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
    Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
    BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma.
    Sui X; Chen C; Zhou X; Wen X; Shi C; Chen G; Liu J; He Z; Yao Y; Li Y; Gao Y
    J Exp Clin Cancer Res; 2023 Feb; 42(1):51. PubMed ID: 36850011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
    Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
    Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.